Stay updated with breaking news from Regeneron Eylea. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Adverum Biotechnologies is cutting 78 jobs after announcing it had successfully amended its Investigational New Drug application for ADVM-022.to treat wet age-related macular degeneration.
The company said that this will be a significant jump from the R&D spending of Rs 310 crore it reported for FY22, which represented 9 per cent of its revenue for the year.
/PRNewswire/ -- Spherix Global Insights, an independent market intelligence firm, recently collected feedback from 103 US ophthalmologists on the neovascular...
/PRNewswire/ -- Spherix Global Insights, an independent market intelligence firm, recently collected feedback from 103 US ophthalmologists on the neovascular...